Literature DB >> 5259278

Metabolism of niridazole in various species, including man.

J W Faigle, H Keberle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5259278     DOI: 10.1111/j.1749-6632.1969.tb15874.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Intestinal schistosomiasis.

Authors:  H A Rowland
Journal:  Gut       Date:  1971-08       Impact factor: 23.059

Review 2.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

3.  The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.

Authors:  A J Wood; D M Kornhauser; G R Wilkinson; D G Shand; R A Branch
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

4.  Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.

Authors:  H Hof; V Sticht-Groh; K M Müller
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

5.  Effect of experimentally-induced hepatic cirrhosis on the pharmacokinetics of orally administered praziquantel in the rat.

Authors:  G O Kokwaro; G Taylor
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

6.  Covalent binding and glutathione depletion in the rat following niridazole (ambilhar) pretreatment.

Authors:  I N Oduah; M I Thabrew; G O Emerole
Journal:  Arch Toxicol       Date:  1985-04       Impact factor: 5.153

7.  Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.

Authors:  H Hof; V Sticht-Groh
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

8.  Effect of niridazole in cellular immunity in vivo and in vitro.

Authors:  W Solbach; H Wagner; M Röllinghoff
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

9.  Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine.

Authors:  M Homeida; S Y Salih; R A Branch
Journal:  Gut       Date:  1978-09       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.